Author [ Title(Asc)] Type Year
Filters: First Letter Of Last Name is K  [Clear All Filters]
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K.  1995.  Thyroid hormone treatment after coronary-artery bypass surgery.. N Engl J Med. 333(23):1522-7.
Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K.  1995.  Thyroid hormone treatment after coronary-artery bypass surgery.. N Engl J Med. 333(23):1522-7.
Klemperer JD, Klein I, Gomez M, Helm RE, Ojamaa K, Thomas SJ, Isom OW, Krieger K.  1995.  Thyroid hormone treatment after coronary-artery bypass surgery.. N Engl J Med. 333(23):1522-7.
Storer KP, Tu J, Karunanayaka A, Morgan MK, Stoodley MA.  2007.  Thrombotic molecule expression in cerebral vascular malformations.. J Clin Neurosci. 14(10):975-80.
Rong LQ, Hameed I, Salemi A, Rahouma M, Khan FM, Wijeysundera HC, Angiolillo DJ, Shore-Lesserson L, Biondi-Zoccai G, Girardi LN et al..  2019.  Three-Dimensional Echocardiography for Transcatheter Aortic Valve Replacement Sizing: A Systematic Review and Meta-Analysis.. J Am Heart Assoc. 8(19):e013463.
Rong LQ, Neuburger PJ, De Paulis S, Kim J.  2019.  Thinking Outside the Heart: An Innovative Approach of Speckle Tracking With Transesophageal Echocardiography.. J Cardiothorac Vasc Anesth.
Fleischut PM, Evans AS, Nugent WC, Faggiani SL, Lazar EJ, Liebowitz RS, Forese LL, Kerr GE.  2011.  Ten years after the IOM report: Engaging residents in quality and patient safety by creating a House Staff Quality Council.. Am J Med Qual. 26(2):89-94.
Jia F, Yue M, Chandra D, Keramidas A, Goldstein PA, Homanics GE, Harrison NL.  2008.  Taurine is a potent activator of extrasynaptic GABA(A) receptors in the thalamus.. J Neurosci. 28(1):106-15.
Roepke TK, Kontogeorgis A, Ovanez C, Xu X, Young JB, Purtell K, Goldstein PA, Christini DJ, Peters NS, Akar FG et al..  2008.  Targeted deletion of kcne2 impairs ventricular repolarization via disruption of I(K,slow1) and I(to,f).. FASEB J. 22(10):3648-60.
Ying S-W, Kanda VA, Hu Z, Purtell K, King EC, Abbott GW, Goldstein PA.  2012.  Targeted deletion of Kcne2 impairs HCN channel function in mouse thalamocortical circuits.. PLoS One. 7(8):e42756.
Ying S-W, Kanda VA, Hu Z, Purtell K, King EC, Abbott GW, Goldstein PA.  2012.  Targeted deletion of Kcne2 impairs HCN channel function in mouse thalamocortical circuits.. PLoS One. 7(8):e42756.
Roepke TK, Purtell K, King EC, La Perle KMD, Lerner DJ, Abbott GW.  2010.  Targeted deletion of Kcne2 causes gastritis cystica profunda and gastric neoplasia.. PLoS One. 5(7):e11451.
S
Fernandez-Alfonso T, Kwan R, Ryan TA.  2006.  Synaptic vesicles interchange their membrane proteins with a large surface reservoir during recycling.. Neuron. 51(2):179-86.
Kim SHyun, Ryan TA.  2009.  Synaptic vesicle recycling at CNS snapses without AP-2.. J Neurosci. 29(12):3865-74.
Kerr S, Kerr GE, Mackintosh CA, Marples RR.  1990.  A survey of methicillin-resistant Staphylococcus aureus affecting patients in England and Wales.. J Hosp Infect. 16(1):35-48.
Kerr S, Kerr GE, Mackintosh CA, Marples RR.  1990.  A survey of methicillin-resistant Staphylococcus aureus affecting patients in England and Wales.. J Hosp Infect. 16(1):35-48.
Naguib M, Kopman AF, Lien CA, Hunter JM, Lopez A, Brull SJ.  2010.  A survey of current management of neuromuscular block in the United States and Europe.. Anesth Analg. 111(1):110-9.
Mackintosh CA, Marples RR, Kerr GE, Bannister BA.  1991.  Surveillance of methicillin-resistant Staphylococcus aureus in England and Wales, 1986-1990.. J Hosp Infect. 18(4):279-92.
Mitchell KB, Giiti G, Kotecha V, Chandika A, Pryor KO, Härtl R, Gilyoma J.  2013.  Surgical education at Weill Bugando Medical Centre: supplementing surgical training and investing in local health care providers.. Can J Surg. 56(3):199-203.
Larach MGreen, Klumpner TT, Brandom BW, Vaughn MT, Belani KG, Herlich A, Kim TW, Limoncelli J, Riazi S, Sivak EL et al..  2019.  Succinylcholine Use and Dantrolene Availability: Reply.. Anesthesiology. 131(4):935-936.
Larach MGreen, Klumpner TT, Brandom BW, Vaughn MT, Belani KG, Herlich A, Kim TW, Limoncelli J, Riazi S, Sivak EL et al..  2019.  Succinylcholine Use and Dantrolene Availability: Reply.. Anesthesiology. 131(4):935-936.
Larach MGreen, Klumpner TT, Brandom BW, Vaughn MT, Belani KG, Herlich A, Kim TW, Limoncelli J, Riazi S, Sivak EL et al..  2019.  Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review.. Anesthesiology. 130(1):41-54.
Larach MGreen, Klumpner TT, Brandom BW, Vaughn MT, Belani KG, Herlich A, Kim TW, Limoncelli J, Riazi S, Sivak EL et al..  2019.  Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review.. Anesthesiology. 130(1):41-54.
Larach MGreen, Klumpner TT, Brandom BW, Vaughn MT, Belani KG, Herlich A, Kim TW, Limoncelli J, Riazi S, Sivak EL et al..  2019.  Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review.. Anesthesiology. 130(1):41-54.
Larach MGreen, Klumpner TT, Brandom BW, Vaughn MT, Belani KG, Herlich A, Kim TW, Limoncelli J, Riazi S, Sivak EL et al..  2019.  Succinylcholine Use and Dantrolene Availability for Malignant Hyperthermia Treatment: Database Analyses and Systematic Review.. Anesthesiology. 130(1):41-54.